LYRA Competitors & Alternatives
Compare Lyra Therapeutics Inc with similar stocks in the same industry
Biotechnology
LYRA
Main Stock$0.50
Tradestie Score
50
Market Cap
$10.80M
Revenue Growth
-0.9%
Analyst Upside
+3132.3%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.62
|
$170.45M | - | 57 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.37
|
$158.43M | - | 57 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.43
|
$154.27M | - | 51 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.59
|
$133.50M | - | 58 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.56
|
$114.01M | - | 57 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.79
|
$110.20M | - | 61 | Compare |
|
PLRX
Pliant Therapeutics, Inc. Common Stock
|
$1.12
|
$89.01M | - | 54 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.19
|
$71.69M | - | 57 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.52
|
$67.94M | - | 58 | Compare |
|
PASG
Passage Bio, Inc. Common Stock
|
$4.94
|
$25.84M | - | 49 | Compare |
More LYRA Analysis
Data updated: Jul 15, 2026 | Industry: Biotechnology (SIC 3841)
232 stocks in this industry